Arcturus Therapeutics is actively engaged in partnering discussions. Our strategic alliances fall into several categories:
- Partnering RNA medicines, including access to LUNAR and UNA Technologies
- Co-Development Opportunities
Please contact bd@arcturusrx.com regarding any business development opportunities.
News & Events
February 11, 2019
Arcturus Therapeutics Reassumes Full Worldwide Rights to ARCT-810, a Clinical Development Candidate for Ornithine Transcarbamylase (OTC) Deficiency